CRISPR Therapeutics to present at three major investor conferences in June 2026

CRISPR Therapeutics announced that its senior management will participate in three key investor conferences in June 2026: Jefferies Global Healthcare Conference on June 3, William Blair’s Growth Stock Conference also on June 3, and Goldman Sachs’ Global Healthcare Conference on June 9. These presentations will be webcast live and archived for 14 days on the company’s website. The events provide CRISPR Therapeutics an opportunity to update investors on its progress, including its pioneering gene-editing therapies like CASGEVY® for sickle cell disease and beta thalassemia, and its expanding pipeline in various disease areas. This engagement highlights the company’s ongoing efforts to advance transformative gene-based medicines and strengthen investor relations.